Saturday, October 07, 2017 10:54:08 PM
Next, we WILL have to go through trials, most of the ongoing concerns for Naltrexone implant is the lack of data to support how one will do. I doubt we will be able to skip trials, but hopefully we can skip a lot of the requirements and go straight into a Phase 3 study, to just get this implant of Naltrexone approved. So I expect a study that is hopefully funded by either the grants or NIH, which will evaluate the safety and efficacy for long term extended release (6 months or so) of Naltrexone.
This approach isn’t new, since Braeburn and Titan has to go through the same thing with Proburphine. I just hope we don’t RS (the way Titan did to get on NASDAQ before they got their implant approved). I hope we get some form of funding from somewhere to keep lights on like TEB mentioned sometime ago.
At the moment, Alkemeres has a ton of cash on hand so they could very well, possibly buy us out. Unfortunately, we don’t lose a threat to their current primarily revenue source (Vivitrol). We need to cut into their profit margins for that to become a reality. There’s too much uncertainty for me to accurately make an estimated SP for upcoming months. I do believe if FDA grants fast track or some form of an expedited review, and we use grant funding from somewhere to pay for those trials. We’ll be in a good position.
With regards to an IND application cost, I believe someone will jump in to cover those costs otherwise we will have to issue more shares to keep moving forward.
I hope in 6-8 months we will be trading @ 0.5
Recent BICX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:19:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2024 05:02:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:38:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 07:53:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 07:47:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 01:44:46 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 03:43:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 12:42:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 09:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:59:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 08:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 08:25:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:15:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:37:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 07:55:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 11:38:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 09:01:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:56:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:50:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:38:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:30:13 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM